Leveraging more than 11 million historical visits, the solution provides industry-first visit-by-visit analytics for machine learning and personalized care recommendations

NASHVILLE, Tennessee., October 24, 2022 /PRNewswire/ — Using the power of machine learning to deliver visit-by-visit analytics that ensure patients receive the right care at the right time, the Medalogix Pulse resource management solution is now available to home healthcare providers across country.

The development of Pulse was driven by the need to strengthen what can be a logistically unwieldy and inefficient home healthcare patient journey, as well as the growing demand for clinical resources given the industry’s staffing shortage. Medalogix Pulse is based on the technology in their flagship products Medalogix Care and Medalogix Muse. The Care solution revealed a nearly 20% reduction in hospitalization rates as well as a 2.4 reduction in visits per episode. Customers using the hospice solution, Muse, have reported an increase of as much as 82% more visits than the national average during end-of-life care.

“Pulse puts machine learning to work for patients and clinicians. Pulse is powered by data from every visit for every patient using OASIS, vital signs, medications, clinician narrative notes and more. Home healthcare teams use our analytics to craft patient-centered care plans,” says Medalogix President and CEO, Elliot Wood. “The goal of Pulse is to identify each patient’s risk of hospitalization after each visit and ensure that the right resources go to the right patients, especially when the original plan of care changes due to new information. Our mission is to help patients have the opportunity to recover safely at home. Today, we’re excited to announce that Pulse is now available to the wider market to advance this mission.”

Bid Langham is EVP of Clinical Excellence and Strategy for Dallasbased at Enhabit Home Health & Hospice, one of the nation’s largest providers and among the first to adopt Medalogix Pulse as a beta user. He says Enhabit’s clinical teams use data to make informed decisions about patient care, and that’s where Pulse offers great value.

“Medalogix Pulse is positioned to provide significant insight into a patient’s condition after each visit, including how patients’ risk of hospitalization is changing,” says Langham. “With this opportunity, we can use Pulse to excel in home health value-based purchasing while strengthening strategic partnerships with payers and ACOs in value-based relationships.” Pulse’s strength lies in its predictive analytics and risk stratification features. Our care teams are becoming more efficient and much better equipped to ensure that every patient gets the level of care they need, when they need it.”

Medalogix Pulse detects patients who are at highest risk and more than 10 times more likely to be hospitalized in the next two weeks than others in the census. Today, more than 30% of all home patients in the US are supported by Medalogix products.

Other Pulse features include risk-based recertification and discharge guidance, as well as insight into non-critical upcoming Low Utilization Payment Adjustments (LUPA). More information about Pulse can be found at


Founded in 2012, Medalogix is ​​a one-of-a-kind data analytics company in the post-acute care space. Transforming home health and hospice agencies by leveraging cutting-edge data science, machine learning and innovative cloud technology to help clinicians and agencies deliver the right care at the right time. The company’s machine learning products demonstrate improved patient outcomes and reduced costs to the healthcare system, including reduced hospitalizations, appropriate and timely transitions to end-of-life care, and optimized utilization of patient visits. For more information, please visit Medalogix at or follow us on LinkedIn @Medalogix.

SOURCE Medalogix

Leave a Comment